ArticleLeukemia2025
MEK inhibitors are effective in Erdheim-Chester disease regardless of MAPK pathway mutations.
Francesco Pegoraro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleLeukemia2025
Francesco Pegoraro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.